The asialoglycoprotein receptor regulates levels of plasma glycoproteins terminating with sialic acid alpha2,6-galactose.
about
Enzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathyRole of sialic acid for platelet life span: exposure of beta-galactose results in the rapid clearance of platelets from the circulation by asialoglycoprotein receptor-expressing liver macrophages and hepatocytes.Extravasated platelet aggregation in liver zone 3 may correlate with the progression of sinusoidal obstruction syndrome following living donor liver transplantation: A case reportGlycoproteomics analysis to identify a glycoform on haptoglobin associated with lung cancer.Comparative pharmacology of a new recombinant FSH expressed by a human cell line.Sialylation and muscle performance: sialic acid is a marker of muscle ageing.Identification of neutrophil granule glycoproteins as Lewis(x)-containing ligands cleared by the scavenger receptor C-type lectin.Extensive mannose phosphorylation on leukemia inhibitory factor (LIF) controls its extracellular levels by multiple mechanismsMacro- and Micro-heterogeneity in Pituitary and Urinary Follicle-Stimulating Hormone Glycosylation.DNA nanocarriers for systemic administration: characterization and in vivo bioimaging in healthy miceA comparison of anti-HER2 IgA and IgG1 in vivo efficacy is facilitated by high N-glycan sialylation of the IgA.MALDI-TOF-MS reveals differential N-linked plasma- and IgG-glycosylation profiles between mothers and their newborns.Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics.Modulation of mannose and asialoglycoprotein receptor expression determines glycoprotein hormone half-life at critical points in the reproductive cycle.Characterizing the effect of GalNAc and phosphorothioate backbone on binding of antisense oligonucleotides to the asialoglycoprotein receptor.Synthetic vectors for gene delivery: An overview of their evolution depending on routes of administration.Treatment efficacy of DNA lipid nanocapsules and DNA multimodular systems after systemic administration in a human glioma model.Variable asialoglycoprotein receptor 1 expression in liver disease: Implications for therapeutic intervention.Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice.NMR study of ligand release from asialoglycoprotein receptor under solution conditions in early endosomes.Asialoglycoprotein receptor 1 mediates productive uptake of N-acetylgalactosamine-conjugated and unconjugated phosphorothioate antisense oligonucleotides into liver hepatocytes.Antisense suppression of the nonsense mediated decay factor Upf3b as a potential treatment for diseases caused by nonsense mutations.Receptor-Mediated Uptake of Phosphorothioate Antisense Oligonucleotides in Different Cell Types of the Liver.Nonclinical comparability studies of recombinant human arylsulfatase A addressing manufacturing process changes.
P2860
Q28539595-80486CB2-2A1C-4B15-ADE3-795C5B2F8856Q33384971-BE4825C2-7A27-4139-8A02-DAC69656E5C5Q33421253-2AA184F3-E0FD-41AD-9DF5-7698908AE0D3Q33888457-8455B1BC-18C4-4B5D-915A-CB66DBA0644BQ33904231-16165F96-CF1F-4550-AF33-A59EC47E5856Q35069379-F7485C74-4743-4F95-9D23-4F098CADA479Q35085154-F573E1BE-4455-4C79-8225-0B4DFDEA675DQ35107460-06EECA42-C876-4565-8934-092B238BF5E9Q35114436-050F3EDB-88AF-4BE7-891A-A81EEAF6C294Q36587584-99A58F1D-BF6D-485F-BEFB-5D9E4665168FQ37138274-33F1640E-E582-41C8-9AC6-20410318B647Q37281976-A8F17012-C982-4106-A78D-33B5D6E012DCQ37718173-F0AFE12F-FD5C-4692-B595-2FAAA38F2BFAQ37727661-17288065-2B40-4BCF-8D2E-D1ED7801E10AQ38289176-F07871BA-EB75-4610-8581-69D51B43A75CQ38513773-CCBE5377-C991-4D8B-B151-D52B7812EAA1Q39246483-9E585243-2BB5-4B56-8B29-171AC58BDB96Q40482454-891BEF9C-642A-47DF-A27E-E83E3FAECF71Q41846059-B114A899-06C2-428E-A89C-A3F466494018Q44929386-09291E15-9125-4D91-806C-B56B4202CD20Q47120143-211A0164-3045-44FA-B0A6-44E7CD99897BQ48241302-ABA6F772-F113-4601-ADB3-AAAA9CD58BD3Q50100050-1C081071-CE2A-41FE-A810-F7620D719621Q55209626-92E5B4C5-5090-4D72-A4D2-7B537944619F
P2860
The asialoglycoprotein receptor regulates levels of plasma glycoproteins terminating with sialic acid alpha2,6-galactose.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
The asialoglycoprotein recepto ...... ialic acid alpha2,6-galactose.
@ast
The asialoglycoprotein recepto ...... ialic acid alpha2,6-galactose.
@en
The asialoglycoprotein recepto ...... ialic acid alpha2,6-galactose.
@nl
type
label
The asialoglycoprotein recepto ...... ialic acid alpha2,6-galactose.
@ast
The asialoglycoprotein recepto ...... ialic acid alpha2,6-galactose.
@en
The asialoglycoprotein recepto ...... ialic acid alpha2,6-galactose.
@nl
prefLabel
The asialoglycoprotein recepto ...... ialic acid alpha2,6-galactose.
@ast
The asialoglycoprotein recepto ...... ialic acid alpha2,6-galactose.
@en
The asialoglycoprotein recepto ...... ialic acid alpha2,6-galactose.
@nl
P2093
P2860
P356
P1476
The asialoglycoprotein recepto ...... ialic acid alpha2,6-galactose.
@en
P2093
Eric I Park
Jacques U Baenziger
Lindsay M Steirer
R Reid Townsend
P2860
P304
P356
10.1074/JBC.M808689200
P407
P577
2008-12-15T00:00:00Z